Literature DB >> 24758578

Military participants at U.S. Atmospheric nuclear weapons testing--methodology for estimating dose and uncertainty.

John E Till1, Harold L Beck, Jill W Aanenson, Helen A Grogan, H Justin Mohler, S Shawn Mohler, Paul G Voillequé.   

Abstract

Methods were developed to calculate individual estimates of exposure and dose with associated uncertainties for a sub-cohort (1,857) of 115,329 military veterans who participated in at least one of seven series of atmospheric nuclear weapons tests or the TRINITY shot carried out by the United States. The tests were conducted at the Pacific Proving Grounds and the Nevada Test Site. Dose estimates to specific organs will be used in an epidemiological study to investigate leukemia and male breast cancer. Previous doses had been estimated for the purpose of compensation and were generally high-sided to favor the veteran's claim for compensation in accordance with public law. Recent efforts by the U.S. Department of Defense (DOD) to digitize the historical records supporting the veterans' compensation assessments make it possible to calculate doses and associated uncertainties. Our approach builds upon available film badge dosimetry and other measurement data recorded at the time of the tests and incorporates detailed scenarios of exposure for each veteran based on personal, unit, and other available historical records. Film badge results were available for approximately 25% of the individuals, and these results assisted greatly in reconstructing doses to unbadged persons and in developing distributions of dose among military units. This article presents the methodology developed to estimate doses for selected cancer cases and a 1% random sample of the total cohort of veterans under study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24758578      PMCID: PMC4082990          DOI: 10.1667/RR13597.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  20 in total

1.  Doses from external irradiation to Marshall Islanders from Bikini and Enewetak nuclear weapons tests.

Authors:  André Bouville; Harold L Beck; Steven L Simon
Journal:  Health Phys       Date:  2010-08       Impact factor: 1.316

2.  Practical considerations in choosing between the case-cohort and nested case-control designs.

Authors:  S Wacholder
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

3.  Study of UK men who had participated in the UK nuclear weapons test programme.

Authors:  R Doll; C Sharp; C Muirhead; S Darby
Journal:  J Radiol Prot       Date:  1998-09       Impact factor: 1.394

4.  Mortality of veteran participants in the CROSSROADS nuclear test.

Authors:  J C Johnson; S Thaul; W F Page; H Crawford
Journal:  Health Phys       Date:  1997-07       Impact factor: 1.316

5.  Male breast cancer incidence among atomic bomb survivors.

Authors:  Elaine Ron; Takayoshi Ikeda; Dale L Preston; Shoji Tokuoka
Journal:  J Natl Cancer Inst       Date:  2005-04-20       Impact factor: 13.506

6.  A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.

Authors:  John D Boice; Richard W Leggett; Elizabeth Dupree Ellis; Phillip W Wallace; Michael Mumma; Sarah S Cohen; A Bertrand Brill; Bandana Chadda; Bruce B Boecker; R Craig Yoder; Keith F Eckerman
Journal:  Health Phys       Date:  2006-05       Impact factor: 1.316

7.  Cancer mortality risk among military participants of a 1958 atmospheric nuclear weapons test.

Authors:  K K Watanabe; H K Kang; N A Dalager
Journal:  Am J Public Health       Date:  1995-04       Impact factor: 9.308

8.  Further follow up of mortality and incidence of cancer in men from the United Kingdom who participated in the United Kingdom's atmospheric nuclear weapon tests and experimental programmes.

Authors:  S C Darby; G M Kendall; T P Fell; R Doll; A A Goodill; A J Conquest; D A Jackson; R G Haylock
Journal:  BMJ       Date:  1993-12-11

9.  Mortality and cancer frequency among military nuclear test (Smoky) participants, 1957 through 1979.

Authors:  G G Caldwell; D Kelley; M Zack; H Falk; C W Heath
Journal:  JAMA       Date:  1983-08-05       Impact factor: 56.272

10.  Leukemia among participants in military maneuvers at a nuclear bomb test. A preliminary report.

Authors:  G G Caldwell; D B Kelley; C W Heath
Journal:  JAMA       Date:  1980-10-03       Impact factor: 56.272

View more
  6 in total

1.  Mortality among military participants at the 1957 PLUMBBOB nuclear weapons test series and from leukemia among participants at the SMOKY test.

Authors:  Glyn G Caldwell; Matthew M Zack; Michael T Mumma; Henry Falk; Clark W Heath; John E Till; Heidi Chen; John D Boice
Journal:  J Radiol Prot       Date:  2016-06-29       Impact factor: 1.394

2.  Chromosome Translocations, Inversions and Telomere Length for Retrospective Biodosimetry on Exposed U.S. Atomic Veterans.

Authors:  Miles J McKenna; Erin Robinson; Lynn Taylor; Christopher Tompkins; Michael N Cornforth; Steven L Simon; Susan M Bailey
Journal:  Radiat Res       Date:  2019-02-04       Impact factor: 2.841

3.  Dose reconstruction for the million worker study: status and guidelines.

Authors:  André Bouville; Richard E Toohey; John D Boice; Harold L Beck; Larry T Dauer; Keith F Eckerman; Derek Hagemeyer; Richard W Leggett; Michael T Mumma; Bruce Napier; Kathy H Pryor; Marvin Rosenstein; David A Schauer; Sami Sherbini; Daniel O Stram; James L Thompson; John E Till; Craig Yoder; Cary Zeitlin
Journal:  Health Phys       Date:  2015-02       Impact factor: 1.316

Review 4.  Strengths and Weaknesses of Dosimetry Used in Studies of Low-Dose Radiation Exposure and Cancer.

Authors:  Robert D Daniels; Gerald M Kendall; Isabelle Thierry-Chef; Martha S Linet; Harry M Cullings
Journal:  J Natl Cancer Inst Monogr       Date:  2020-07-01

5.  The Likelihood of Adverse Pregnancy Outcomes and Genetic Disease (Transgenerational Effects) from Exposure to Radioactive Fallout from the 1945 Trinity Atomic Bomb Test.

Authors:  John D Boice
Journal:  Health Phys       Date:  2020-10       Impact factor: 2.922

6.  Shared dosimetry error in epidemiological dose-response analyses.

Authors:  Daniel O Stram; Dale L Preston; Mikhail Sokolnikov; Bruce Napier; Kenneth J Kopecky; John Boice; Harold Beck; John Till; Andre Bouville
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.